Letter re: Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022

Saved in:
Bibliographic Details
Main Authors: Lilienfeld-Toal, Marie von (Author) , Agkatsev, S. (Author) , Glasmacher, A. (Author) , Reiß, P. (Author) , Sen, S. (Author) , Seltmann, A. (Author) , Wolf, S. (Author)
Format: Article (Journal)
Language:English
Published: May 2025
In: ESMO open
Year: 2025, Volume: 10, Issue: 5, Pages: 1
ISSN:2059-7029
DOI:10.1016/j.esmoop.2025.105062
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.esmoop.2025.105062
Verlag, kostenfrei, Volltext: https://www.esmoopen.com/article/S2059-7029(25)00931-7/fulltext
Get full text
Author Notes:M. von Lilienfeld-Toal, S. Agkatsev, A. Glasmacher, P. Reiß, S. Sen, A. Seltmann & S. Wolf
Description
Item Description:Online veröffenticht: 11. April 2025
Gesehen am 20.11.2025
Physical Description:Online Resource
ISSN:2059-7029
DOI:10.1016/j.esmoop.2025.105062